Risk Factors for Post‑retrograde Cholangiopancreatography Pancreatitis in Patients with Common Bile Duct Stones: A Meta‑analysis

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2023 Dec 21

PMID 38125338

Authors

Bo Zhou

Liyuan Zhao

Xinfeng Xing

Hai Wang

Asihati Kuwantai

Kai Chen

Affiliations

Soon will be listed here.

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) has become a common treatment method for common bile duct stones. However, ERCP is also associated with a high risk of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP). Identification of risk factors is essential for reducing the incidence of PEP. The present study aimed to summarize the risk factors for PEP by performing a meta-analysis. Therefore, studies published between 2000 and 2022 were screened in PubMed, Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang Digital Periodicals and the Weipu Database, with no language restrictions. Newcastle-Ottawa Scale was used to assess the quality of the included studies. Stata 17.0 software was utilized for the meta-analysis of 14 possible risk factors. Overall, 15 high-quality studies were included into the present meta-analysis. The results showed that female [odds ratio (OR), 1.42; 95% CI, 1.23-1.64), age <60 years (OR, 1.53; 95% CI, 1.06-2.21), difficult intubation (OR, 4.87; 95% CI, 2.73-8.68), ≥3 cannulation attempts (OR, 9.64; 95% CI, 4.16-22.35), cannulation time ≥10 min (OR, 2.37; 95% CI, 1.67-3.35), history of pancreatitis (OR, 2.95; 95% CI, 1.06-5.51), pancreatic duct visualization (OR, 3.63; 95% CI, 2.47-5.34) and sphincter of Oddi dysfunction (OR, 5.72; 95% CI, 1.80-18.24) are potential risk factors for PEP (P<0.05). In conclusion, the present meta-analysis suggests that PEP can be affected by several risk factors, particularly the technique-related factors such as the frequency and time of cannulation. Therefore, effective precautions should be taken as early as possible to reduce the incidence of PEP.

References

Koksal A, Boga S, Alkim H, Sen I, Neijmann S, Alkim C . Chemerin: a new biomarker to predict postendoscopic retrograde cholangiopancreatography pancreatitis. Eur J Gastroenterol Hepatol. 2016; 28(6):714-21. DOI: 10.1097/MEG.0000000000000597. View

Saito H, Kadono Y, Kamikawa K, Urata A, Imamura H, Matsushita I . The Incidence of Complications in Single-stage Endoscopic Stone Removal for Patients with Common Bile Duct Stones: A Propensity Score Analysis. Intern Med. 2017; 57(4):469-477. PMC: 5849540. DOI: 10.2169/internalmedicine.9123-17. View

Saito H, Kadono Y, Shono T, Kamikawa K, Urata A, Nasu J . Increased post-endoscopic retrograde cholangiopancreatography pancreatitis for choledocholithiasis without acute cholangitis. J Gastroenterol Hepatol. 2021; 37(2):327-334. DOI: 10.1111/jgh.15704. View

Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M . Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001; 96(2):417-23. DOI: 10.1111/j.1572-0241.2001.03594.x. View

Swahn F, Nilsson M, Arnelo U, Lohr M, Persson G, Enochsson L . Rendezvous cannulation technique reduces post-ERCP pancreatitis: a prospective nationwide study of 12,718 ERCP procedures. Am J Gastroenterol. 2013; 108(4):552-9. DOI: 10.1038/ajg.2012.470. View

von Seth E, Arnelo U, Enochsson L, Bergquist A . Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography. Liver Int. 2014; 35(1):254-62. DOI: 10.1111/liv.12640. View

Park J, Shin S, Cho S, Lee J, Kim J, Kang C . Triglyceride and glucose (TyG) index is an effective biomarker to identify severe acute pancreatitis. Pancreatology. 2020; 20(8):1587-1591. DOI: 10.1016/j.pan.2020.09.018. View

Gooshe M, Abdolghaffari A, Nikfar S, Mahdaviani P, Abdollahi M . Antioxidant therapy in acute, chronic and post-endoscopic retrograde cholangiopancreatography pancreatitis: An updated systematic review and meta-analysis. World J Gastroenterol. 2015; 21(30):9189-208. PMC: 4533052. DOI: 10.3748/wjg.v21.i30.9189. View

Kuo C, Chiu Y, Liang C, Lu L, Tai W, Kuo Y . Limited precut sphincterotomy combined with endoscopic papillary balloon dilation for common bile duct stone removal in patients with difficult biliary cannulation. BMC Gastroenterol. 2016; 16(1):70. PMC: 4941015. DOI: 10.1186/s12876-016-0486-4. View

10.

Fogel E, Eversman D, Jamidar P, Sherman S, Lehman G . Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy. 2002; 34(4):280-5. DOI: 10.1055/s-2002-23629. View

11.

Sousa M, Pinho R, Proenca L, Rodrigues J, Silva J, Gomes C . Choledocholithiasis in elderly patients with gallbladder in situ - is ERCP sufficient?. Scand J Gastroenterol. 2018; 53(10-11):1388-1392. DOI: 10.1080/00365521.2018.1524022. View

12.

Saito H, Kakuma T, Matsushita I . Risk factors for the development of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with asymptomatic common bile duct stones. World J Gastrointest Endosc. 2019; 11(10):515-522. PMC: 6885445. DOI: 10.4253/wjge.v11.i10.515. View

13.

Fujita K, Yazumi S, Matsumoto H, Asada M, Nebiki H, Matsumoto K . Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis. Dig Endosc. 2021; 34(6):1198-1204. PMC: 9540598. DOI: 10.1111/den.14225. View

14.

Meister T, Heinzow H, Heinecke A, Hoehr R, Domschke W, Domagk D . Post-ERCP pancreatitis in 2364 ERCP procedures: is intraductal ultrasonography another risk factor?. Endoscopy. 2011; 43(4):331-6. DOI: 10.1055/s-0030-1256194. View

15.

Tsujino T, Isayama H, Isayana H, Komatsu Y, Ito Y, Tada M . Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation. Am J Gastroenterol. 2005; 100(1):38-42. DOI: 10.1111/j.1572-0241.2005.40638.x. View

16.

Andriulli A, Clemente R, Solmi L, Terruzzi V, Suriani R, Sigillito A . Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc. 2002; 56(4):488-95. DOI: 10.1067/mge.2002.128130. View

17.

Wang P, Li Z, Liu F, Ren X, Lu N, Fan Z . Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2008; 104(1):31-40. DOI: 10.1038/ajg.2008.5. View

18.

Cianci P, Restini E . Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches. World J Gastroenterol. 2021; 27(28):4536-4554. PMC: 8326257. DOI: 10.3748/wjg.v27.i28.4536. View

19.

Nakai Y, Kusumoto K, Itokawa Y, Inatomi O, Bamba S, Doi T . Emergency Endoscopic Retrograde Cholangiopancreatography Did Not Increase the Incidence of Postprocedural Pancreatitis Compared With Elective Cases: A Prospective Multicenter Observational Study. Pancreas. 2022; 51(1):41-47. PMC: 8865204. DOI: 10.1097/MPA.0000000000001958. View

20.

Berry R, Han J, Tabibian J . Difficult biliary cannulation: Historical perspective, practical updates, and guide for the endoscopist. World J Gastrointest Endosc. 2019; 11(1):5-21. PMC: 6354112. DOI: 10.4253/wjge.v11.i1.5. View